These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32299831)

  • 1. Patent foramen ovale.
    Alakbarzade V; Keteepe-Arachi T; Karsan N; Ray R; Pereira AC
    Pract Neurol; 2020 May; 20(3):225-233. PubMed ID: 32299831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL;
    J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.
    West BH; Noureddin N; Mamzhi Y; Low CG; Coluzzi AC; Shih EJ; Gevorgyan Fleming R; Saver JL; Liebeskind DS; Charles A; Tobis JM
    Stroke; 2018 May; 49(5):1123-1128. PubMed ID: 29636424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent foramen ovale (PFO): is there life before death in the presence of PFO?
    Seiler C
    Eur J Clin Invest; 2015 Aug; 45(8):875-82. PubMed ID: 26017145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptogenic Stroke and Patent Foramen Ovale.
    Mojadidi MK; Zaman MO; Elgendy IY; Mahmoud AN; Patel NK; Agarwal N; Tobis JM; Meier B
    J Am Coll Cardiol; 2018 Mar; 71(9):1035-1043. PubMed ID: 29495983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patent foramen ovale and stroke].
    Mas JL
    Rev Prat; 2021 Feb; 71(2):177-181. PubMed ID: 34160980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale: thromboembolic structure or incidental finding?
    Torbey E; Thompson PD
    Conn Med; 2011 Feb; 75(2):97-105. PubMed ID: 21476380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study.
    Mas JL; Guillon B; Charles-Nelson A; Domigo V; Derex L; Massardier E; Arquizan C; Vuillier F; Timsit S; Béjot Y; Detante O; Sablot D; Guidoux C; Sibon I; Dequatre-Ponchelle N; Touzé E; Canaple S; Alamowitch S; Aubry P; Teiger E; Derumeaux G; Chatellier G;
    Eur J Neurol; 2021 Aug; 28(8):2700-2707. PubMed ID: 33938088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
    Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent right-to-left shunt is the key factor in managing patent foramen ovale.
    Rigatelli G; Dell'Avvocata F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Mandapaka S; Kuruvilla J; Chen JP; Nanjundappa A
    J Am Coll Cardiol; 2011 Nov; 58(21):2257-61. PubMed ID: 22078434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Patent Foramen Ovale Closure More Effective Than Medical Therapy in Preventing Stroke Recurrence in Patients With Cryptogenic Stroke?: A Critically Appraised Topic.
    Valencia-Sanchez C; Fortuin FD; Sweeney JP; Ingall TJ; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2018 Sep; 23(5):175-180. PubMed ID: 30169372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.